Gabriele Kaltenecker

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

Sherko Küemmel, Joerg Heil, Anna Rueland et al. · Annals of Surgery · 2020 · 170 citations

Medicine, Oncology, Surgery +16

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

Silvia Darb‐Esfahani, Gϋnter von Minckwitz, Carsten Denkert et al. · BMC Cancer · 2014 · 87 citations · Full text

Medicine, Endocrinology, Oncology +16

Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany

Steffi Hartmann, Thorsten Kühn, Michael Hauptmann et al. · Geburtshilfe und Frauenheilkunde · 2022 · 23 citations · Full text

Medicine, Oncology, Surgery +17

Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of <scp>HR</scp>‐positive/<scp>HER2</scp>‐negative metastatic breast cancer with real‐world data from the <scp>OPAL</scp> registry

Marc Thill, Mark‐Oliver Zahn, Anja Welt et al. · International Journal of Cancer · 2024 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

Steffi Hartmann, Malgorzata Banys-Paluchowski, Elmar Stickeler et al. · Breast Cancer Research and Treatment · 2023 · 16 citations · Full text

Medicine, Oncology, Radiology +17